A Randomized, Phase III Clinical Trial GF-GS 01 to Compare Conventional Axillary Dissection Versus Sentinel Node Resection (GS) in Clinically Node-negative Operable Breast Cancer Unifocal N0 Patients
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Survival without recurrence
5 years
Yes
Gilles HOUVENAEGHEL, MD
Principal Investigator
Institut Paoli Calmette
France: Ministry of Health
2003.312
NCT00144898
July 2003
August 2013
Name | Location |
---|